Showing results (281-290 of 329) with videos related to

Sort By:
Pageof 33
Seminars in Oncology|September 5, 1998
Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug deliveryR P Abratt, A Sandler, L Crinò, et al.
The Journal of Investigative Dermatology|December 1, 1986
Rapid isolation in large numbers of intact, viable, individual hair follicles from skin: biochemical and ultrastructural characterizationM R Green, C S Clay, W T Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group BE E Vokes, A P Lyss, J E Herndon, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
Irinotecan in the management of patients with pancreatic cancerM R Green, M Harper, A Safa, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1995
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B studyJ J Muscato, C Cirrincione, G Clamon, et al.
Archives of Disease in Childhood|July 13, 2007
Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover studyM A Thomson, H R Jenkins, W M Bisset, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLCC M Rocha Lima, N A Rizvi, C Zhang, et al.
Seminars in Oncology|February 1, 1992
Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experienceM R Green, H Kreisman, D C Doll, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreasE S Casper, M R Green, D P Kelsen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group BN J Vogelzang, M Goutsou, J M Corson, et al.
Pageof 33